niacin has been researched along with Peripheral Vascular Diseases in 56 studies
Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.
Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.
Excerpt | Relevance | Reference |
---|---|---|
" In our study, patients were randomized, on average, 6 days after an acute myocardial infarction and/or percutaneous transluminal coronary angioplasty secondary to unstable angina, to pravastatin (combined, when necessary, with cholestyramine and/or nicotinic acid) to achieve low-density lipoprotein cholesterol levels of < or =130 mg/dl (group A, n = 70)." | 9.09 | Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). ( Agrawal, R; Arntz, HR; Fischer, F; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W, 2000) |
" In our study, patients were randomized, on average, 6 days after an acute myocardial infarction and/or percutaneous transluminal coronary angioplasty secondary to unstable angina, to pravastatin (combined, when necessary, with cholestyramine and/or nicotinic acid) to achieve low-density lipoprotein cholesterol levels of < or =130 mg/dl (group A, n = 70)." | 5.09 | Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). ( Agrawal, R; Arntz, HR; Fischer, F; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W, 2000) |
"After an active run-in period, participants were randomly assigned to receive niacin (crystalline nicotinic acid), 3000 mg/d or maximum tolerated dosage (n = 64 with diabetes; n = 173 without diabetes), or placebo (n = 61 with diabetes; n = 170 without diabetes) for up to 60 weeks (12-week active run-in and 48-week double-blind)." | 2.69 | Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial. ( Brinton, EA; Davis, KB; Egan, D; Elam, MB; Garg, R; Hunninghake, DB; Johnson, C; Kostis, JB; Sheps, DS, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 50 (89.29) | 18.7374 |
1990's | 3 (5.36) | 18.2507 |
2000's | 3 (5.36) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
ROMANO, G | 1 |
VINDIGNI, E | 1 |
VECCHI, GP | 1 |
RUBBIANI, V | 1 |
VOLKMANN, E | 1 |
JACQUET, M | 1 |
MUTH, HW | 2 |
OSTAPOWICZ, G | 2 |
UHLMANN, WJ | 1 |
HASSE, HM | 1 |
MORHARD, WR | 1 |
KREBS, P | 1 |
HEGER, N | 1 |
DEWITZ, A | 1 |
HIRSCH, W | 1 |
FEINDT, H | 1 |
GUAGLIANO, G | 1 |
STOPPANI, L | 1 |
VASILE, B | 1 |
SOMMARIVA, V | 1 |
RAPISARDA, LM | 1 |
COSSIO, P | 1 |
STEINKE, HJ | 1 |
ZARRILLI, L | 2 |
DE BELLIS, E | 2 |
BERGE, T | 1 |
JOHANSEN, E | 1 |
ASSMANN, F | 1 |
CHITIL, W | 1 |
ORTNER, H | 1 |
BRUNNER, F | 1 |
FALK, G | 1 |
LERCHE, W | 1 |
GENTHOFF, H | 1 |
NEIKES, K | 1 |
KAPPERT, A | 1 |
MAGLIULO, V | 1 |
SERRA, GC | 1 |
BRUN, F | 1 |
PLAUCHU, G | 1 |
PERRIN, A | 1 |
EHLERS, G | 1 |
EHRENBERG, H | 1 |
SPERLING, M | 1 |
GOLDBERG, S | 1 |
GUERRA, G | 1 |
JOHNE, HO | 1 |
BRANZI, G | 1 |
ANNINO, G | 1 |
ABRAMSON, DI | 1 |
SIVORI, A | 1 |
RODRIGUEZNIETO, AJ | 1 |
VALLSSERRA, J | 1 |
MAZZEO, F | 1 |
SPAMPINATO, N | 1 |
CORSALE, C | 1 |
LIOTTA, S | 1 |
KOWALSKA, M | 1 |
CUCCO, G | 1 |
HAMILTON, RR | 1 |
SCHOGER, GA | 2 |
SCHOGER-VON SCHOLZ, I | 1 |
SIEGENTHALER, P | 1 |
PUGLIONISI, A | 1 |
TATTONI, G | 1 |
DI CIO, AV | 1 |
SCHTEINGART, M | 1 |
KLEIN, L | 1 |
Klinke, JA | 1 |
Málek, F | 1 |
Gao, M | 1 |
Holmes, D | 1 |
Frohlich, JJ | 1 |
Schectman, G | 1 |
Hiatt, J | 1 |
Egan, DA | 2 |
Garg, R | 3 |
Wilt, TJ | 1 |
Pettinger, MB | 2 |
Davis, KB | 3 |
Crouse, J | 1 |
Herd, JA | 1 |
Hunninghake, DB | 2 |
Sheps, DS | 2 |
Kostis, JB | 2 |
Probstfield, J | 1 |
Waclawiw, MA | 2 |
Applegate, W | 1 |
Elam, MB | 2 |
Thomason, T | 1 |
Griffin, B | 1 |
Johnson, C | 1 |
Egan, D | 1 |
Brinton, EA | 1 |
Arntz, HR | 1 |
Agrawal, R | 1 |
Wunderlich, W | 1 |
Schnitzer, L | 1 |
Stern, R | 1 |
Fischer, F | 1 |
Schultheiss, HP | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
[NCT00000539] | Phase 3 | 0 participants | Interventional | 1992-09-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 trials available for niacin and Peripheral Vascular Diseases
Article | Year |
---|---|
Compliance to multiple interventions in a high risk population.
Topics: Adult; Aged; Anticholesteremic Agents; Anticoagulants; Antioxidants; Aspirin; Data Interpretation, S | 1999 |
Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial.
Topics: Aged; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Double-Blind | 2000 |
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Chemopreven | 2000 |
53 other studies available for niacin and Peripheral Vascular Diseases
Article | Year |
---|---|
[Tetrahydrofurfuryl ester of nicotinic acid in the treatment of peripheral vascular diseases].
Topics: Furans; Niacin; Nicotinic Acids; Peripheral Vascular Diseases | 1952 |
[Several cases of peripheral vascular diseases treated with tetrahydrofurfurylic ester of nicotinic acid].
Topics: Furans; Humans; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Plethysmography | 1953 |
[Nicotinic acid therapy of peripheral circulatory disorders].
Topics: Cardiovascular Diseases; Gangrene; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular D | 1953 |
[Local administration of the cobalt salt of benzenesulfonic acid and the chloride or nicotinate salts of the cobalt derivative of hexamine in peripheral circulatory syndromes].
Topics: Benzenesulfonates; Chlorides; Cobalt; Ions; Methenamine; Niacin; Peripheral Vascular Diseases; Salts | 1954 |
[Magnesium nicotinate in arterial blood circulation disorders].
Topics: Cardiovascular Diseases; Magnesium; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular | 1956 |
[Magnesium nicotinate in arterial blood circulation disorders].
Topics: Cardiovascular Diseases; Magnesium; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular | 1956 |
[Magnesium nicotinate in arterial blood circulation disorders].
Topics: Cardiovascular Diseases; Magnesium; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular | 1956 |
[Magnesium nicotinate in arterial blood circulation disorders].
Topics: Cardiovascular Diseases; Magnesium; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular | 1956 |
[Medicinal treatment of peripheral blood circulation disorders].
Topics: Bile Acids and Salts; Cardiovascular Diseases; Humans; Magnesium; Niacin; Nicotinic Acids; Periphera | 1956 |
[Medicinal treatment of peripheral blood circulation disorders].
Topics: Bile Acids and Salts; Cardiovascular Diseases; Humans; Magnesium; Niacin; Nicotinic Acids; Periphera | 1956 |
[Medicinal treatment of peripheral blood circulation disorders].
Topics: Bile Acids and Salts; Cardiovascular Diseases; Humans; Magnesium; Niacin; Nicotinic Acids; Periphera | 1956 |
[Medicinal treatment of peripheral blood circulation disorders].
Topics: Bile Acids and Salts; Cardiovascular Diseases; Humans; Magnesium; Niacin; Nicotinic Acids; Periphera | 1956 |
[Differential diagnosis and treatment of red hands with special reference to substances producing hyperemia].
Topics: Diagnosis, Differential; Disease; Erythema; Hand; Hyperemia; Niacin; Nicotinic Acids; Peripheral Vas | 1957 |
[Clinical investigations on the effect of intra-arterial infusions of acetylcholine, pyridostigmine bromide and beta-pyridylcarbinol in arterial obliterative diseases].
Topics: Acetylcholine; Infusions, Intra-Arterial; Niacin; Nicotinic Acids; Nicotinyl Alcohol; Parasympathomi | 1957 |
[Treatment of peripheral circulation disorders with progresin].
Topics: Bile Acids and Salts; Cardiovascular Diseases; Niacin; Nicotinic Acids; Peripheral Vascular Diseases | 1957 |
[Treatment of peripheral blood circulation disorders with acetylcholine, nicotinic acid derivatives and cholinesterase antagonists].
Topics: Acetylcholine; Cardiovascular Diseases; Cholinesterases; Niacin; Nicotinic Acids; Parasympathomimeti | 1957 |
[Policlinical contribution to the treatment of peripheral arterial circulation disorders].
Topics: Bile Acids and Salts; Niacin; Nicotinic Acids; Peripheral Arterial Disease; Peripheral Vascular Dise | 1957 |
[Clinical contribution to the treatment of autonomic circulation disorders].
Topics: Autonomic Nervous System; Autonomic Nervous System Diseases; Cardiovascular Diseases; Humans; Niacin | 1957 |
[Treatment of peripheral vascular diseases in tuberculous patients with progresin].
Topics: Bile Acids and Salts; Humans; Magnesium; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Salt | 1957 |
[Nicotinamide hydroiodide in the treatment of degenerative arterial diseases].
Topics: Humans; Niacin; Niacinamide; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases | 1957 |
[Proposed new durg cocktail in medical therapy of chronic obliterating arteriopathy].
Topics: Anti-Allergic Agents; Ergot Alkaloids; Hibernation; Histamine H1 Antagonists; Hypothermia, Induced; | 1958 |
[Changes in the electrophoretic picture of lipoproteins and glycoprotein fractions in arterial and venous blood of patients of arterial diseases after drug cocktail therapy].
Topics: Blood Proteins; Electrophoresis; Ergot Alkaloids; Histamine H1 Antagonists; Lipoproteins; Niacin; Pa | 1958 |
The treatment of angina pectoris and other muscular pain due to ischemia with iproniazid and isoniazid.
Topics: Angina Pectoris; Humans; Iproniazid; Ischemia; Isoniazid; Niacin; Nicotinic Acids; Peripheral Vascul | 1958 |
[Therapeutic effects of various nicotinic acid derivatives in peripheral & cerebral circulatory disorders].
Topics: Brain; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases | 1958 |
[Elimination of nicotinic acid in patients with chronic obstructive arteriopathy of the lower extremities].
Topics: Lower Extremity; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases | 1958 |
[Elimination of N'-methylnicotinamide in patients with arteriopathies after surgical intervention].
Topics: Niacin; Niacinamide; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases | 1958 |
[Hexanicit in arterial insufficiency of the lower extremities].
Topics: Humans; Lower Extremity; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases | 1958 |
[Therapy of peripheral blood circulation disorders with reference to diabetic gangrene].
Topics: Diabetes Complications; Diabetic Angiopathies; Gangrene; Humans; Niacin; Nicotinic Acids; Peripheral | 1959 |
[Peripheral blood circulation disorders and their physical treatment with special reference to iontophoresis with nicotinates].
Topics: Cardiovascular Diseases; Ion Exchange; Iontophoresis; Niacin; Nicotinic Acids; Peripheral Vascular D | 1959 |
[Clinical experiences with the nicotinic acid ester of hydroxyethltheophylline (hesotin) in the treatment of cerebral & peripheral circulation disorders].
Topics: Brain; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Theophylline; Vascular Diseases | 1959 |
[Clinical contribution to the treatment of peripheral circulation disorders with Complamine].
Topics: Cardiovascular Diseases; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Theophylline; Vascul | 1961 |
[A contribution to improvement in the results of surgery of the sympathetic nervous system (with a study on blood supply of the muscles)].
Topics: Muscles; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Sympathectomy; Sympathetic Nervous S | 1960 |
[Nicotinic acid in the treatment of vascular diseases].
Topics: Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases | 1960 |
[Experimental and clinical experiences with Complamine in disorders of cerebral and peripheral circulation].
Topics: Brain; Cardiovascular System; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Theophylline; V | 1961 |
[The hexa-nicotinic acid ester of m-inositol in the treatment of peripheral vascular diseases. Clinical results].
Topics: Hexosaminidase A; Humans; Inositol; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular | 1961 |
[Demonstration on a trial treatment with Euclidan injected by the intra-arterial route of severe ischemic conditions of the lower limbs].
Topics: Lower Extremity; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases; Vasodilat | 1962 |
[Experiences in the treatment of arterial and venous blood circulation disorders, including ulcus cruris, with a nicotinic acid-xanthine derivative].
Topics: Humans; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Ulcer; Varicose Ulcer; Vascular Disea | 1961 |
[Results of long-term therapy with Complamin].
Topics: Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Theophylline; Vascular Diseases; Xanthinol Ni | 1961 |
[Clinical trial of the treatment of peripheral circulation disorders with Complamine].
Topics: Cardiovascular Diseases; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Theophylline; Vascul | 1962 |
[Magnesium compositum-a new medication for the treatment of peripheral arterial circulatory disorders].
Topics: Humans; Magnesium; Niacin; Nicotinic Acids; Peripheral Arterial Disease; Peripheral Vascular Disease | 1963 |
[Our experience with tetranicotinoyl-fructose in the treatment of peripheral vascular diseases].
Topics: Fructose; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases; Vasodilator Agen | 1962 |
[Experiences in the treatment of peripheral vascular diseases with Lipocapsul].
Topics: Amino Alcohols; Fatty Acids; Humans; Inositol; Intermittent Claudication; Leg Ulcer; Niacin; Periphe | 1963 |
[Therapy of peripheral arteriopathies with a compound with a base of inositol hexanicotinate].
Topics: Inositol; Niacin; Nicotinic Acids; Peripheral Arterial Disease; Peripheral Vascular Diseases; Pyrido | 1963 |
DRUGS USED IN PERIPHERAL VASCULAR DISEASES.
Topics: Deoxyribonuclease I; Dihydroergotoxine; Endopeptidases; Ergot Alkaloids; Ganglionic Blockers; Histam | 1963 |
[CURRENT THERAPY OF PERIPHERAL VASCULAR DISEASES].
Topics: Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases; Xanthines | 1964 |
[CLINICAL STUDY OF TETRANICOTINOYLFRUCTOSE IN THE TREATMENT OF PERIPHERAL ANGIOPATHIES].
Topics: Amputation Stumps; Anticoagulants; Biomedical Research; Fructose; Humans; Hypertension; Niacin; Nico | 1964 |
[3-(METHYLHYDROXYETHYLAMINO)-2-HYDROXYPROPYLTHEOPHYLLINE NICOTINATE IN THE TREATMENT OF PERIPHERAL ARTERIOPATHIES].
Topics: Angiography; Drug Therapy; Geriatrics; Humans; Niacin; Nicotinic Acids; Peripheral Arterial Disease; | 1964 |
[FIRST EXPERIENCES ON THE THERAPEUTIC ACTIVITY OF M-INOSITOL HEXANICOTINATE AND KALLIKREIN IN PERIPHERAL VASCULAR DISEASES AND IN CORONARY DISEASE].
Topics: Coronary Disease; Electric Impedance; Electrocardiography; Humans; Kallikreins; Niacin; Nicotinic Ac | 1964 |
[VASPERDIL IN THE TREATMENT OF PERIPHERAL VASCULAR DISEASES].
Topics: Drug Therapy; Fructose; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases | 1964 |
[Diverse pharmacodynamic action of vasomotor drugs on peripheral circulation; experimental research on the blood-ciliary barrier and conclusions regarding clinical practice and therapy].
Topics: Humans; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases | 1955 |
Speripheral vascular disease in general practice. Some experiences with meso-inositol-hexanicotinate.
Topics: General Practice; Inositol; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases | 1960 |
[Results of inositol-nicotinic acid therapy in the treatment of blood circulation disorders].
Topics: Cardiovascular Diseases; Inositol; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular D | 1959 |
[On the appropriate treatment of peripheral circulation disorders in private practice].
Topics: Cardiovascular Diseases; Inositol; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Private Pr | 1960 |
[The influence on peripheral circulation disorders and on blood cholesterol of a nicotinic acid derivative (ES 304), administered in high doses].
Topics: Cardiovascular Diseases; Cholesterol; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascula | 1960 |
[Effect of tetrahydro-furfuryl ester of nicotinic acid (Trafuril) in the therapy of peripheral arteriopathy].
Topics: Arteries; Furans; Niacin; Nicotinic Acids; Peripheral Vascular Diseases | 1952 |
[Effect of associated sodium citrate and sodium phosphate with nicotinic acid in certain peripheral vascular diseases].
Topics: Citrates; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Phosphates; Sodium Citrate | 1952 |
Reaching target lipid levels in patients at high risk of cardiovascular event: the experience of a Canadian tertiary care lipid clinic.
Topics: Body Mass Index; Canada; Cardiovascular Diseases; Cohort Studies; Diabetes Complications; Dyslipidem | 2007 |
Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals.
Topics: Aged; Anticholesteremic Agents; Cholesterol, LDL; Colestipol; Coronary Disease; Female; Gemfibrozil; | 1996 |
Rationale and design of the Arterial Disease Multiple Intervention Trial (ADMIT) pilot study.
Topics: Adult; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mi | 1999 |